Springer Nature
Browse
13023_2021_2166_MOESM5_ESM.png (33.23 kB)

Additional file 5 of Postmarketing safety of orphan drugs: a longitudinal analysis of the US Food and Drug Administration database between 1999 and 2018

Download (33.23 kB)
figure
posted on 2022-01-05, 04:37 authored by Min Fan, Adrienne Y. L. Chan, Vincent K. C. Yan, Xinning Tong, Lauren K. W. Lau, Eric Y. F. Wan, Eliza Y. T. Tam, Patrick Ip, Terry Y. Lum, Ian C. K. Wong, X. Li
Additional file 5. Schoenfeld residuals plots for proportional hazard assumption checking

Funding

lks faculty of medicine, university of hong kong department of medicine, university of hong kong

History

Usage metrics

    Orphanet Journal of Rare Diseases

    Categories

    Keywords

    Orphan drug designationAdverse eventsPostmarketing surveillanceMedication safetyRisk–benefit trade-off

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC